In conclusion, we identified a novel role for MICAL2 in the regulation of gastric cancer cell migration, and showed that the underlying mechanism involved the impaired binding of E-cadherin to β-catenin in the cytoplasm, subsequently leading to the accumulation of β-catenin in the nucleus. The gene discussed is MICAL2; the disease is gastric cancer.